Alto Neuroscience ANRO
NYSE ANRO
$25.38 -0.19 (-0.74%)
As of: Oct 1, 2026 · 9:31 AM EDT

Alto Neuroscience (ANRO) Other Non-Current Liabilities (2023)

Updated

Alto Neuroscience (ANRO) posted Other Non-Current Liabilities of $1.35 million for Q4 2023, down 3.4% from the prior quarter.

Analysis

Alto Neuroscience (ANRO) Other Non-Current Liabilities (2023) Analysis & Trends

Since Q1 2023, Alto Neuroscience has reported Other Non-Current Liabilities for 4 quarters.

  • According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $1.4 million (Q3 2023), $1.6 million (Q2 2023) and $1.7 million (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Alto Neuroscience 897.35 Mn 897.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.35 Mn
Sep 30, 2023 1.40 Mn
Jun 30, 2023 1.60 Mn
Mar 31, 2023 1.70 Mn
API Access

Alto Neuroscience Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ANRO&period=max&api_key=YOUR_API_KEY